Replies to post #89 on Trinity Biotech (TRIB)

[surf1944]

4. Trinity Biotech plc (TRIB): Develops, manufactures, distributes, and sells diagnostic test kits and instrumentation worldwide. Market cap at $232.30M. Price at $10.70. PEG at 0.92. Revenue grew by 3.95% during the most recent quarter ($20.01M vs. $19.25M y/y). Accounts receivable grew by -6.45% during the same time period ($24.09M vs. $25.75M y/y). Receivables, as a percentage of current assets, decreased from 25.41% to 20.95% during the most recent quarter (comparing 3 months ending 2011-12-31 to 3 months ending 2010-12-31).

http://seekingalpha.com/article/493441-5-undervalued-healthcare-stocks-with-positive-receivables-trends?source=yahoo